Insider Trading April 17, 2026 08:05 AM

Herzfeld Chairman Adds to Position in Herz Credit Income Fund

Thomas J. Herzfeld buys 3,610 HERZ shares; fund shows high yield and liquidity pressure

By Leila Farooq HERZ
Herzfeld Chairman Adds to Position in Herz Credit Income Fund
HERZ

Thomas J. Herzfeld, chairman of the advisor to Herzfeld Credit Income Fund, Inc. (HERZ), acquired 3,610 shares of the closed-end fund on April 15, 2026, at $16.0141 per share for a total of $57,810. The transaction leaves Herzfeld with 197,248 shares. The fund currently trades at $16.69, is down 25% year-to-date, carries an 82% dividend yield, and faces short-term obligations that exceed liquid assets.

Key Points

  • Thomas J. Herzfeld purchased 3,610 shares of Herzfeld Credit Income Fund on April 15, 2026, at $16.0141 per share, totaling $57,810.
  • Post-transaction, Herzfeld directly owns 197,248 shares; the fund trades at $16.69 and is down 25% year-to-date.
  • The fund carries an 82% dividend yield and has paid dividends for 15 consecutive years; cited analysis notes short-term obligations exceed liquid assets.

Transaction details

Thomas J. Herzfeld, who serves as chairman of the advisor to Herzfeld Credit Income Fund, Inc. (EXCHANGE: HERZ), made an open-market purchase of 3,610 shares of the fund's common stock on April 15, 2026. The shares were bought at a price of $16.0141 each, bringing the total value of the trade to $57,810.

Position after the purchase

Following the acquisition, Herzfeld's direct holding in Herzfeld Credit Income Fund stands at 197,248 shares. The fund's prevailing market price at the time of reporting is $16.69 per share, and the shares are down 25% year-to-date.

Dividend and liquidity snapshot

The fund displays an 82% dividend yield. According to InvestingPro Tips, Herzfeld Credit Income Fund has maintained dividend payments for 15 consecutive years. The same note flags a liquidity point of concern: the fund's short-term obligations exceed its liquid assets. Additional analysis and financial metrics are available through four further ProTips on the InvestingPro platform.


Context for investors

This report records the reported insider purchase and restates current, reported financial metrics and ownership levels. It does not attempt to assess causation or future outcomes beyond the specific, reported items: the trade, the resulting ownership figure, the fund's market price and year-to-date performance, the stated dividend yield, and the liquidity observation cited in the InvestingPro Tips.

Where to find more information

Investors interested in supplemental ProTips and detailed financial metrics may consult the InvestingPro service referenced in the fund's note for the four additional ProTips and the broader set of financial data it offers.


Note on reporting

The foregoing summarizes the reported insider transaction and the specific, attributed statements about dividend history and liquidity. Where the publicly reported material provides limited detail, that limitation is reflected rather than supplemented with inference.

Risks

  • Short-term obligations exceed liquid assets, a liquidity risk explicitly noted for the fund - impacts fixed-income and closed-end fund investors.
  • Shares are down 25% year-to-date, reflecting market price risk for holders of the fund's stock.
  • An 82% dividend yield is exceptionally high and, combined with the liquidity observation, presents uncertainty around dividend sustainability - relevant to income-focused investors.

More from Insider Trading

OrbiMed Expands Stake in Traws Pharma via Strategic Private Placement Apr 28, 2026 Rexford Industrial Realty General Counsel Completes $1.18 Million Stock Sale Apr 28, 2026 Bicara Therapeutics CMO Executes Rule 10b5-1 Trading Plan Involving Share Sales and Option Exercises Apr 28, 2026 Abbott Laboratories Director Daniel Starks Executes Substantial Open Market Share Purchase Apr 28, 2026 BlackRock President Robert Kapito Executes $9.2 Million Share Sale Apr 28, 2026